Evidence map›Paper›PMID 36386653›Full record

ReviewFrontiers in microbiology2022

Erythrocyte tropism of malarial parasites: The reticulocyte appeal.

Yew Wai Leong, Bruce Russell, Benoit Malleret, Laurent Rénia

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Targeting anemia-induced CD71Infection and immunity · 2025
    Article
  6. Article
  7. Review
  8. Cells · 2024
    Review
  9. Article
  10. Article
  11. Tropical medicine and infectious disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Yew Wai LeongASTAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore, Singapore.
Bruce RussellDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Benoit MalleretSingapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Laurent RéniaASTAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore, Singapore.
Agency for Science, Technology and Research · SGSingapore Immunology Network · SGUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythrocytes are formed from the enucleation of erythroblasts in the bone marrow, and as erythrocytes develop from immature reticulocytes into mature normocytes, they undergo extensive cellular changes through their passage in the blood. During the blood stage of the malarial parasite life cycle, the parasite sense and invade susceptible erythrocytes. However, different parasite species display varying erythrocyte tropisms (i.e., preference for either reticulocytes or normocytes). In this review, we explore the erythrocyte tropism of malarial parasites, especially their predilection to invade reticulocytes, as shown from recent studies. We also discuss possible mechanisms mediating erythrocyte tropism and the implications of specific tropisms to disease pathophysiology. Understanding these allows better insight into the role of reticulocytes in malaria and provides opportunities for targeted interventions.

Indexed as

bone marrowerythrocyte invasionerythrocyte tropismgametocytenormocytereticulocytezoonotic malaria

Identifiers

PMID36386653
PMCPMC9643692
OpenAlexW4307553310

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.